Infants and the elderly share a high vulnerability to infections and therefore have specific
immunization requirements. Inducing potent and sustained B-cell responses is as challenging …

To generate vaccine-mediated protection is a complex challenge. Currently available
vaccines have largely been developed empirically, with little or no understanding on how they …

Major histocompatibility complex (MHC) class II genes are expressed constitutively in only a
few cell types, but they can be induced in the majority of them, in particular by interferon-γ (…

Preclinical and human vaccine studies indicate that, although neonatal immunisation does
not generally lead to rapid and strong antibody responses, it may result in an efficient …

Background The replication-competent recombinant vesicular stomatitis virus (rVSV)–based
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …

Successful neonatal immunization of humans has proven difficult. We have evaluated CpG-containing
oligonucleotides as an adjuvant for immunization of young mice (1–14 days old) …

The persistence of serum IgG antibodies elicited in human infants is much shorter than
when such responses are elicited later in life. The reasons for this rapid waning of antigen-…

Interleukin-12 receptor A1 (IL-12RA1) deficiency is the most common form of Mendelian
susceptibility to mycobacterial disease (MSMD). We undertook an international survey of 141 …

… Claire-Anne Siegrist (Geneva) discussed practices now in use in which infants receive
multiple vaccinations and demonstrated that interactions between vaccine components can …

Background Although fever is part of the normal inflammatory process after immunisation,
prophylactic antipyretic drugs are sometimes recommended to allay concerns of high fever …